187 related articles for article (PubMed ID: 21980434)
1. Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis.
Pradhan AK; Mohapatra AD; Nayak KB; Chakraborty S
PLoS One; 2011; 6(9):e25370. PubMed ID: 21980434
[TBL] [Abstract][Full Text] [Related]
2. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
[TBL] [Abstract][Full Text] [Related]
3. Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles.
Chakraborty S; Senyuk V; Sitailo S; Chi Y; Nucifora G
J Biol Chem; 2001 Nov; 276(48):44936-43. PubMed ID: 11568182
[TBL] [Abstract][Full Text] [Related]
4. Physical and functional interaction of the proto-oncogene EVI1 and tumor suppressor gene HIC1 deregulates Bcl-xL mediated block in apoptosis.
Pradhan AK; Halder A; Chakraborty S
Int J Biochem Cell Biol; 2014 Aug; 53():320-8. PubMed ID: 24907396
[TBL] [Abstract][Full Text] [Related]
5. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
Singh S; Pradhan AK; Chakraborty S
Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
[TBL] [Abstract][Full Text] [Related]
6. EVI1 up-regulates the stress responsive gene SIRT1 which triggers deacetylation and degradation of EVI1.
Pradhan AK; Kuila N; Singh S; Chakraborty S
Biochim Biophys Acta; 2011; 1809(4-6):269-75. PubMed ID: 21555002
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of lysine 564 adjacent to the C-terminal binding protein-binding motif in EVI1 is crucial for transcriptional activation of GATA2.
Shimahara A; Yamakawa N; Nishikata I; Morishita K
J Biol Chem; 2010 May; 285(22):16967-77. PubMed ID: 20363750
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
9. The oncoprotein EVI1 and the DNA methyltransferase Dnmt3 co-operate in binding and de novo methylation of target DNA.
Senyuk V; Premanand K; Xu P; Qian Z; Nucifora G
PLoS One; 2011; 6(6):e20793. PubMed ID: 21695170
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Nishikawa S; Arai S; Masamoto Y; Kagoya Y; Toya T; Watanabe-Okochi N; Kurokawa M
Blood; 2014 Dec; 124(24):3587-96. PubMed ID: 25298035
[TBL] [Abstract][Full Text] [Related]
11. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R
Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480
[TBL] [Abstract][Full Text] [Related]
12. Identification of binding sites of EVI1 in mammalian cells.
Yatsula B; Lin S; Read AJ; Poholek A; Yates K; Yue D; Hui P; Perkins AS
J Biol Chem; 2005 Sep; 280(35):30712-22. PubMed ID: 16006653
[TBL] [Abstract][Full Text] [Related]
13. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
[TBL] [Abstract][Full Text] [Related]
14. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
15. Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis.
Senyuk V; Zhang Y; Liu Y; Ming M; Premanand K; Zhou L; Chen P; Chen J; Rowley JD; Nucifora G; Qian Z
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5594-9. PubMed ID: 23509296
[TBL] [Abstract][Full Text] [Related]
16. EVI1 promotes tumor growth via transcriptional repression of MS4A3.
Heller G; Rommer A; Steinleitner K; Etzler J; Hackl H; Heffeter P; Tomasich E; Filipits M; Steinmetz B; Topakian T; Klingenbrunner S; Ziegler B; Spittler A; Zöchbauer-Müller S; Berger W; Wieser R
J Hematol Oncol; 2015 Mar; 8():28. PubMed ID: 25886616
[TBL] [Abstract][Full Text] [Related]
17. Functional features of EVI1 and EVI1Δ324 isoforms of MECOM gene in genome-wide transcription regulation and oncogenicity.
Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells.
Ezzat S; Zhu X; Loeper S; Fischer S; Asa SL
Mol Endocrinol; 2006 Nov; 20(11):2976-86. PubMed ID: 16873443
[TBL] [Abstract][Full Text] [Related]
19. The forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor.
Tang TT; Dowbenko D; Jackson A; Toney L; Lewin DA; Dent AL; Lasky LA
J Biol Chem; 2002 Apr; 277(16):14255-65. PubMed ID: 11777915
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of Evi1, a zinc finger oncogene involved in myeloid leukemia.
Lopingco MC; Perkins AS
Curr Top Microbiol Immunol; 1996; 211():211-22. PubMed ID: 8585952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]